Table 2: Distribution of anti-Ro52 antibodies through connective tissue diseases.

PM/DM 𝑛 (%)SLE 𝑛 (%)Sjögren 𝑛 (%)Mixed CTD 𝑛 (%)U CTD 𝑛 (%)P Neo 𝑛 (%)P

PARo52A13 (76.5)7 (77.8)2 (100)8 (100)3 (100)2 (100)0.668*

PARo52A, positive anti-Ro52 antibodies; PM/DM, polymyositis dermatomyositis; SLE, systemic lupus erythematosus; CTD, connective tissue diseases; U, undifferentiated; P Neo, paraneoplastic.
*Fischer test.